Post navigation Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune DiseasesQuantification and transcriptome profiling reveal abundant, dynamic and translatable dephospho-CoA-capped RNAs